113 related articles for article (PubMed ID: 4242114)
1. [Clinical experiences with the preparation Seniosan].
Pernhaupt G
Med Monatsschr; 1969 Oct; 23(10):461-4. PubMed ID: 4242114
[No Abstract] [Full Text] [Related]
2. [Studies with Seniosan in arteriosclerosis of the abdominal aorta and-or lower extremities].
Blomquist HE
Ann Chir Gynaecol Fenn; 1968; 57(2):218-20. PubMed ID: 4237173
[No Abstract] [Full Text] [Related]
3. [New aspects in the therapy of cerebrovascular diseases. Hemodynamic studies with a combination of coumarin-rutin-theophylline].
Klein K
Arzneimittelforschung; 1974 Jul; 24(7):1066-9. PubMed ID: 4408076
[No Abstract] [Full Text] [Related]
4. [Clinical ophthalmodynamographic results of the treatment of cerebral circulation disorders with O-(beta-hydroxyethyl)-rutoside].
Tzavellas O
Arzneimittelforschung; 1970 Sep; 20(9):1187-90. PubMed ID: 5536794
[No Abstract] [Full Text] [Related]
5. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
Bompani R; Violi G
Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
[No Abstract] [Full Text] [Related]
6. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
Castello S
Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
[No Abstract] [Full Text] [Related]
7. [Experience in the treatment of arteriosclerotic circulatory disorders using Seniosan in the general practice].
Rölke H
Med Welt; 1969 Mar; 13():746-50. PubMed ID: 4185050
[No Abstract] [Full Text] [Related]
8. [Clinical experiences with proxazole in the therapy of cerebrovascular diseases].
Mainieri L
Minerva Med; 1974 May; 65(40):2281-6. PubMed ID: 4422429
[No Abstract] [Full Text] [Related]
9. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
Lozeron H
Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
[No Abstract] [Full Text] [Related]
10. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
Ciammaichella A; Solitro A; Torcia L; Arcuri P
Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
[No Abstract] [Full Text] [Related]
11. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
[No Abstract] [Full Text] [Related]
12. [Treatment of cerebrovascular insufficiency].
Cosentino F; Baldassarri R
Clin Ter; 1979 Mar; 88(6):631-8. PubMed ID: 380878
[No Abstract] [Full Text] [Related]
13. [Experiences with Wy 4036, a new tranquilizing agent from the benzodiazepine group].
Appel P; Berger I; Harrer G
Arzneimittelforschung; 1971 Jul; 21(7):1083-6. PubMed ID: 4935400
[No Abstract] [Full Text] [Related]
14. [Clinical use of a new vasoactive drug : nicergoline].
Mellini M
Minerva Med; 1973 May; 64(34):1844-53. PubMed ID: 4719381
[No Abstract] [Full Text] [Related]
15. Proxazole in cerebrovascular insufficiency. A controlled clinical trial.
Esposito G; De Gregorio M
Arzneimittelforschung; 1974 Oct; 24(10):1692-6. PubMed ID: 4611436
[No Abstract] [Full Text] [Related]
16. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
[No Abstract] [Full Text] [Related]
17. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
Probst G; Keiser G
Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
[No Abstract] [Full Text] [Related]
18. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
[No Abstract] [Full Text] [Related]
19. [Value of Calgam in the treatment of cerebrovascular diseases].
Wasilewski R; Kossowska W; Rubach K
Pol Tyg Lek; 1971 Mar; 26(9):316-8. PubMed ID: 5550673
[No Abstract] [Full Text] [Related]
20. [Treatment of mental manifestations of chronic cerebral circulatory insufficiency. Clinical and psychometric study].
Lefebvre P; Crocq L; Bernard JG
Sem Hop; 1969 Jan; 45(5):312-7. PubMed ID: 4307724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
